Skip to main content
Top
Published in: Rheumatology International 8/2008

01-06-2008 | Original Article

Early Rheumatoid Arthritis in Italy: study of incidence based on a two-level strategy in a sub-area of Florence (Scandicci-Le Signe)

Authors: Maurizio Benucci, Emanuela Cammelli, Mariangela Manfredi, Gianantonio Saviola, Paola Baiardi, Alessandro Mannoni, AMES (Associazione Medici-Scandicci)

Published in: Rheumatology International | Issue 8/2008

Login to get access

Abstract

The concept of Early Arthritis represents a new diagnostic–therapeutic strategy in modern rheumatology. Even if many Early Arthritis clinics are starting up, we do not yet know the frequency of this pathology in the Italian population. With the collaboration of 20 general practictioners (GPs) operating in the municipalities of Scandicci, Lastra a Signa and Signa, we assessed the incidence of rheumatoid arthritis and of new cases of Early Rheumatoid Arthritis (ERA) in the period from 1.09.2005 to 31.08.2006. The general population over 18 years old in the three municipalities according to the political electoral lists in April 2006 was as follows: Scandicci 42,474 (Males 20,290; Females 22,184), Lastra a Signa 15,368 (M 7,458; F 7,910) and Signa 13,372 (M 6,439; F 6,933). The total number of patients followed by the 20 GPs was 32,521 according to the records of ASL10 Florence. In one year 920 patients were referred by their GPs to a rheumatologist with suspected early undifferentiated arthritis according to Emery’s criteria. The patients underwent a rheumatological examination and the rheumatoid factor IgM, hidden rheumatoid factors (IgG and IgA) and IgG antibodies anti-CCP (anti-cyclic citrullinate peptides) with a semiquantitative immuno-enzymatic test ELISA were investigated. In one year we observed 32 new cases of Rheumatoid Arthritis, of which 8 were males and 24 were females. The rate of incidence with respective intervals of confidence of 95% was 0.98‰ (0.64−1.32‰). The average age was 47.7 ± 10.5 in the females and 54.9 ± 10.3 in the males. The patients had an average history of illness in months of 5.2 ± 1.3 F versus 4.6 ± 1.1 M, number of tender joints 6.2 ± 2.3 F versus 5.3 ± 2.2 M, number of swollen joints 4.8 ± 1.4 F versus 4.2 ± 1.5 M, a global assessment of 64.3 ± 10 F versus 53 ± 12 M, ESR (mm/h) 49.2 ± 11.3 F versus 43.3 ± 12.5 M, CRP (mg/dl) 2.8 ± 1.3 F versus 2.3 ± 1.4 M, DAS28 5.55 ± 1.2 F versus 5.19 ± 1.3 M, HAQ 2.5 ± 0.4 F, 2.2 ± 0.3 M. The rates of incidence in the Italian population affected by early rheumatoid arthritis are higher than those found in some European populations, such as those of the UK and Finland, but less than those found in the population of USA. The different data reported in the literature seem to be due to the different methods of assessing ERA and to the different types of samples studied.
Literature
1.
go back to reference Hitchon CA, Peschken CA, Shaikh S, El-Gabalawy HS (2005) Early undifferentiated arthritis. Rheum Dis Clin N Am 31:605–626CrossRef Hitchon CA, Peschken CA, Shaikh S, El-Gabalawy HS (2005) Early undifferentiated arthritis. Rheum Dis Clin N Am 31:605–626CrossRef
2.
go back to reference Smolen JS, Aletaha D, Machold KP (2005) Therapeutic strategies in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 19:163–177PubMedCrossRef Smolen JS, Aletaha D, Machold KP (2005) Therapeutic strategies in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 19:163–177PubMedCrossRef
3.
go back to reference Aletaha D, Breedveld FC, Smolen JS (2005) The need for new classification citeria for rheumatoid arthritis. Arthritis Rheum 52:3333–3336PubMedCrossRef Aletaha D, Breedveld FC, Smolen JS (2005) The need for new classification citeria for rheumatoid arthritis. Arthritis Rheum 52:3333–3336PubMedCrossRef
4.
go back to reference Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, Emery P, Ferraccioli G, Hazes JM, Klareskog L, Machold K, Martin-Mola E, Nielsen H, Silman A, Smolen J, Yazici H (2007) EULAR recommendations for the management of early arthritis. Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 66(1):34–45PubMedCrossRef Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, Emery P, Ferraccioli G, Hazes JM, Klareskog L, Machold K, Martin-Mola E, Nielsen H, Silman A, Smolen J, Yazici H (2007) EULAR recommendations for the management of early arthritis. Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 66(1):34–45PubMedCrossRef
5.
go back to reference Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS (2002) Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 61:290–297PubMedCrossRef Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS (2002) Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 61:290–297PubMedCrossRef
6.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324PubMedCrossRef
7.
go back to reference Alamanos Y, Voulgari PV, Drosos AA (2006) Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 36(3):182–188PubMedCrossRef Alamanos Y, Voulgari PV, Drosos AA (2006) Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 36(3):182–188PubMedCrossRef
8.
go back to reference Drosos AA, Alamanos I, Voulgari PV, Psychos DN, Katsaraki A, Papadopoulos I, Dimou G, Siozos C (1997) Epidemiology of adult rheumatoid arthritis in northwest Greece 1987–1995. J Rheumatol 24(11):2129–2133PubMed Drosos AA, Alamanos I, Voulgari PV, Psychos DN, Katsaraki A, Papadopoulos I, Dimou G, Siozos C (1997) Epidemiology of adult rheumatoid arthritis in northwest Greece 1987–1995. J Rheumatol 24(11):2129–2133PubMed
9.
go back to reference Guillemin F, Briancon S, Klein JM, Sauleau E, Pourel J (1994) Low incidence of rheumatoid arthritis in France. Scand J Rheumatol 23(5):264–268PubMedCrossRef Guillemin F, Briancon S, Klein JM, Sauleau E, Pourel J (1994) Low incidence of rheumatoid arthritis in France. Scand J Rheumatol 23(5):264–268PubMedCrossRef
10.
go back to reference Soderlin MK, Borjesson O, Kautiainen H, Skogh T, Leirisalo-Repo M (2002) Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann Rheum Dis 61(10):911–915PubMedCrossRef Soderlin MK, Borjesson O, Kautiainen H, Skogh T, Leirisalo-Repo M (2002) Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann Rheum Dis 61(10):911–915PubMedCrossRef
11.
go back to reference Symmons DP, Barrett EM, Bankhead CR, Scott DG, Silman AJ (1994) The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol 33(8):735–739PubMedCrossRef Symmons DP, Barrett EM, Bankhead CR, Scott DG, Silman AJ (1994) The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. Br J Rheumatol 33(8):735–739PubMedCrossRef
12.
go back to reference Uhlig T, Kvien TK, Glennas A, Smedstad LM, Forre O (1998) The incidence and severity of rheumatoid arthritis, results from a county register in Oslo, Norway. J Rheumatol 25(6):1078–1084PubMed Uhlig T, Kvien TK, Glennas A, Smedstad LM, Forre O (1998) The incidence and severity of rheumatoid arthritis, results from a county register in Oslo, Norway. J Rheumatol 25(6):1078–1084PubMed
13.
go back to reference Riise T, Jacobsen BK, Gran JT (2000) Incidence and prevalence of rheumatoid arthritis in the county of Troms, northern Norway. J Rheumatol 27(6):1386–1389PubMed Riise T, Jacobsen BK, Gran JT (2000) Incidence and prevalence of rheumatoid arthritis in the county of Troms, northern Norway. J Rheumatol 27(6):1386–1389PubMed
14.
go back to reference Kaipiainen-Seppanen O, Aho K (2000) Incidence of chronic inflammatory joint diseases in Finland in 1995. J Rheumatol 27(1):94–100 ReviewPubMed Kaipiainen-Seppanen O, Aho K (2000) Incidence of chronic inflammatory joint diseases in Finland in 1995. J Rheumatol 27(1):94–100 ReviewPubMed
15.
go back to reference Kaipiainen-Seppanen O, Aho K, Nikkarinen M (2001) Regional differences in the incidence of rheumatoid arthritis in Finland in 1995. Ann Rheum Dis 60(2):128–132PubMedCrossRef Kaipiainen-Seppanen O, Aho K, Nikkarinen M (2001) Regional differences in the incidence of rheumatoid arthritis in Finland in 1995. Ann Rheum Dis 60(2):128–132PubMedCrossRef
16.
go back to reference Savolainen E, Kaipiainen-Seppanen O, Kroger L, Luosujarvi R (2003) Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey. J Rheumatol 30(11):2460–2468PubMed Savolainen E, Kaipiainen-Seppanen O, Kroger L, Luosujarvi R (2003) Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey. J Rheumatol 30(11):2460–2468PubMed
17.
go back to reference Chan KW, Felson DT, Yood RA, Walker AM (1993) Incidence of rheumatoid arthritis in central Massachusetts. Arthritis Rheum 36(12):1691–6PubMedCrossRef Chan KW, Felson DT, Yood RA, Walker AM (1993) Incidence of rheumatoid arthritis in central Massachusetts. Arthritis Rheum 36(12):1691–6PubMedCrossRef
18.
go back to reference Doran MF, Pond GR, Crowson CS, O’Fallon WM, Gabriel SE (2002) Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 46(3):625–631PubMedCrossRef Doran MF, Pond GR, Crowson CS, O’Fallon WM, Gabriel SE (2002) Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 46(3):625–631PubMedCrossRef
19.
go back to reference Gabriel SE, Crowson CS, O’Fallon WM (1999) The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955–1985. Arthritis Rheum 42(3):415–420PubMedCrossRef Gabriel SE, Crowson CS, O’Fallon WM (1999) The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955–1985. Arthritis Rheum 42(3):415–420PubMedCrossRef
20.
go back to reference Wiles N, Symmons DP, Harrison B, Barrett E, Barrett JH, Scott DG, Silman AJ (1999) Estimating the incidence of rheumatoid arthritis: trying to hit a moving target? Arthritis Rheum 42(7):1339–1346PubMedCrossRef Wiles N, Symmons DP, Harrison B, Barrett E, Barrett JH, Scott DG, Silman AJ (1999) Estimating the incidence of rheumatoid arthritis: trying to hit a moving target? Arthritis Rheum 42(7):1339–1346PubMedCrossRef
21.
go back to reference Hernandez-Avila M, Liang MH, Willett WC, Stampfer MJ, Colditz GA, Rosner B, Chang RW, Hennekens CH, Speizer FE (1990) Exogenous sex hormones and the risk of rheumatoid arthritis. Arthritis Rheum 33(7):947–953PubMedCrossRef Hernandez-Avila M, Liang MH, Willett WC, Stampfer MJ, Colditz GA, Rosner B, Chang RW, Hennekens CH, Speizer FE (1990) Exogenous sex hormones and the risk of rheumatoid arthritis. Arthritis Rheum 33(7):947–953PubMedCrossRef
22.
go back to reference van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL, Toes RE, Huizinga TW (2004) Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 50(3):709–715PubMedCrossRef van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL, Toes RE, Huizinga TW (2004) Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 50(3):709–715PubMedCrossRef
23.
go back to reference Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JM (2002) How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 46(2):357–365PubMedCrossRef Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JM (2002) How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 46(2):357–365PubMedCrossRef
24.
go back to reference Visser H (2005) Early diagnosis of rheumatoid arthritis. Best Pract Res Clin Rheumatol 19(1):55–72. ReviewPubMedCrossRef Visser H (2005) Early diagnosis of rheumatoid arthritis. Best Pract Res Clin Rheumatol 19(1):55–72. ReviewPubMedCrossRef
25.
go back to reference Forslind K, Hafstrom I, Ahlmen M, Svensson B, the BARFOT Study Group (2007) Sex: a major predictor of remission in early rheumatoid arthritis? Ann Rheum Dis 66(1):46–52PubMedCrossRef Forslind K, Hafstrom I, Ahlmen M, Svensson B, the BARFOT Study Group (2007) Sex: a major predictor of remission in early rheumatoid arthritis? Ann Rheum Dis 66(1):46–52PubMedCrossRef
26.
go back to reference Hallert E, Thyberg I, Hass U, Skargren E, Skogh T (2003) Comparison between women and men with recent onset rheumatoid arthritis of disease activity and functional ability over two years (the TIRA project). Ann Rheum Dis 62(7):667–670PubMedCrossRef Hallert E, Thyberg I, Hass U, Skargren E, Skogh T (2003) Comparison between women and men with recent onset rheumatoid arthritis of disease activity and functional ability over two years (the TIRA project). Ann Rheum Dis 62(7):667–670PubMedCrossRef
Metadata
Title
Early Rheumatoid Arthritis in Italy: study of incidence based on a two-level strategy in a sub-area of Florence (Scandicci-Le Signe)
Authors
Maurizio Benucci
Emanuela Cammelli
Mariangela Manfredi
Gianantonio Saviola
Paola Baiardi
Alessandro Mannoni
AMES (Associazione Medici-Scandicci)
Publication date
01-06-2008
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 8/2008
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0527-6

Other articles of this Issue 8/2008

Rheumatology International 8/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine